US Patent Issued to United Therapeutics on April 15 for "Treatment of vasculopathy with prostacyclin and mesenchymal stem cells" (North Carolina Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,684, issued on April 15, was assigned to United Therapeutics Corp. (Silver Spring, Md.).

"Treatment of vasculopathy with prostacyclin and mesenchymal stem cells" was invented by Roger Jeffs (Chapel Hill, N.C.), Thomas Petersen (Durham, N.C.), Roger M. Ilagan (Burlington, N.C.) and Michael Wade (Chapel Hill, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are methods for treating or preventing vasculopathy in a subject in need thereof, comprising administering to the subject a prostacyclin and a mesenchymal stem cell (MSC) or a MSC-conditioned culture medium or administering to the subject a MSC or a MSC-conditioned culture medium that ha...